| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 600.00M | 1.11B | 558.00M | 1.50B | 433.00M | 443.00M |
| Gross Profit | 525.00M | 937.00M | 480.00M | 1.44B | 417.00M | 425.00M |
| EBITDA | -410.00M | 313.00M | -462.00M | 496.00M | -442.00M | -404.00M |
| Net Income | -444.00M | 210.00M | -466.00M | 377.00M | -397.00M | -212.00M |
Balance Sheet | ||||||
| Total Assets | 27.53B | 22.34B | 21.78B | 24.61B | 21.05B | 20.41B |
| Cash, Cash Equivalents and Short-Term Investments | 9.07B | 3.97B | 5.45B | 9.22B | 8.49B | 7.39B |
| Total Debt | 474.00M | 318.00M | 353.00M | 268.00M | 359.00M | 515.00M |
| Total Liabilities | 11.94B | 6.07B | 6.06B | 7.67B | 5.71B | 4.49B |
| Stockholders Equity | 15.59B | 16.26B | 15.72B | 16.94B | 15.34B | 15.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 237.00M | -2.92B | 770.00M | 370.00M | -1.10B |
| Operating Cash Flow | 0.00 | 243.00M | -2.91B | 831.00M | 383.00M | -1.09B |
| Investing Cash Flow | 0.00 | -348.00M | 769.00M | -419.00M | -160.00M | 205.00M |
| Financing Cash Flow | 0.00 | -47.00M | -160.00M | -47.00M | -48.00M | -123.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥7.18B | 4.97 | ― | 4.08% | 19.97% | 38.76% | |
76 Outperform | ¥6.97B | 14.92 | ― | 3.66% | 18.33% | 74.44% | |
75 Outperform | ¥69.64B | 12.02 | 9.22% | 6.15% | 13.26% | 31.92% | |
70 Outperform | ¥5.17B | 14.35 | ― | 1.12% | 99.28% | ― | |
68 Neutral | ¥38.37B | 18.08 | 7.66% | 5.47% | 12.83% | 32.86% | |
68 Neutral | ¥44.71B | 16.68 | ― | 4.36% | 3.23% | -11.76% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |